ENTITY

Capricor Therapeutics (CAPR US)

5
Analysis
Health CareUnited States
Capricor Therapeutics, Inc. operates as a clinical stage biotechnology company. The Company focuses on the development and commercialization of biological therapies for the treatment of duchenne muscular dystrophy (DMD) and other rare disorders. Capricor Therapeutics serves healthcare sector in the United States and Canada.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x